维普中文期刊产品整合服务
27篇 您的检索式:作者名="Hayman MA"
    题名 作者 年代 出处 被引量
1Pomalidomide (CC40M7) plus low-dose dexamethasone as therapy for relapsed multiple myeloma显示文摘Lacy MQ Hayman SR Gertz MA 0,,:1
2Regarding 'Phenobarbital for Acute Alcohol Withdrawal: A Prospec- tive Randomized Double-Blind Placebo-Controlled Study' 显示文摘RIGGAN MA HAYMAN K CHEN BC 2016J Emerg Med2016,,:1
3Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)显示文摘Lacy MQ Hayman SR Gertz MA 0,,:1
4Combination therapy with thalidomide plus dexamthasone for newly diagnosed myeloma显示文摘Rajkumar SV Hayman S Gertz MA 2002J Clin Oncol2002,20,21:1
5Combination therapy with thalidomide plus dexamethasone for newly diagnosed myoloma显示文摘Rajkumar SV Hayman S Gertz MA 2002J clin Oncol2002,20,21:1
6Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)显示文摘LACY MQ HAYMAN SR GERTZ MA 2010Leukemia2010,24,11:1
7Longterm results of single-agent thalidomide as initial therapy for asymptomatic(smoldering or indolent)myeloma显示文摘Detweiler-Short K Hayman S Gertz MA 2010Am J Hematol2010,85,:1
8Treatment of immunoglobulin light chain(primary or AL)amyloidosis显示文摘Gertz MA Buadi FK Hayman SR 2011Oncology(Williston Park)2011,25,:1
9Long- term results of single - agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma 显示文摘Detweiler-Short K Hayman S Gertz MA 2010Am J Hematol2010,85,10:1
10Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma显示文摘Rajkumar SV Hayman S Gertz MA 2002J Clin Oncol2002,20,21:1
11Pomalidomide (CC4047) plus low- dose dexamethasone as therapy for relapsed multiple myeloma 显示文摘Lacy MQ Hayman SR Gertz MA 2009J Clin Oncol2009,27,30:1
12Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma显示文摘Rajkumar SV Hayman S Gertz MA 0,,:1
13Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma显示文摘Rajkumar SV Hayman S Gertz MA 2002J Clin Oncol2002,20,21:1
14Treatment of primary systemic amyloidosis (AL) :role of intensive and standard therapy显示文摘Sher T Hayman SR Gertz MA 2012Clin Adv Hematol Oncol2012,10,10:1
15Pomalidomide(CC4047)plus low-dose dexamethasone as therapy for relapsed multiple myeloma显示文摘Lacy MQ Hayman SR Gertz MA 2009J Clin Oncol2009,27,:1
16Pomalidomide(CC4047)plus low-dose dexamethasone as therapy for relapsed multiple mye-loma显示文摘Lacy MQ Hayman SR Gertz MA 2009J Clin Oncol2009,27,30:1
17Pomalidomide(CC4047)plus low dose dexamethasone(Pom/dex)is active and well tolera-ted in lenalidomide refractory multiple myeloma(MM)显示文摘Lacy MQ Hayman SR Gertz MA 2010Leuke-mia2010,24,11:1
18The classification of affective disorders-a reassessment of the bipolar-unipolar dichotomy: a clini- cal, laboratory, and family study 显示文摘Taylor MA Abrams R Hayman MA 1980J Affect Disord1980,2,2:1
19Use of the serum free light chain assay in assessment of response to therapy in muhiple myeloma 显示文摘Kumar S Gertz MA Hayman SR 2005Blood2005,106,34:1
20Pomalidomide(CC4047)plus low-dose dexamethasone as therapy for relapsed multiple myeloma显示文摘Lacy MQ Hayman SR Gertz MA 2009Journal of Clinical Oncology2009,27,30:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费